Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial (original) (raw)

References

  1. Bagshawe, K. D. (1987) Antibody directed enzymes revive anticancer prodrugs concept.Br. J. Cancer 56, 531,532.
    Google Scholar
  2. Bagshawe, K. D., Springer, C. J., Searle, F., Antoniw, P., Sharma, S. K., Melton, R. G., and Sherwood, R. F. (1988) A cytotoxic agent can be generated selectively at cancer sites.Br. J. Cancer 58, 700–703.
    PubMed CAS Google Scholar
  3. Senter, P. D., Saulnier, M. G., Schreiber, G. J., Hirschberg, D. L., Brown, J. P., Hellstrom, I. N., and Hellstrom, K. E. (1988) Anti-tumour effects of antibody-alkaline-phosphatase conjugates in combination with etoposide phosphate.Proc. Natl. Acad. Sci. USA 85, 4842–4846.
    Article PubMed CAS Google Scholar
  4. Springer, C. J., Antoniw, P., Bagshawe, K. D., Searle, F., Bissett, G. M. F., and Jarman, M. (1990) Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2.J. Med. Chem. 33, 677–681.
    Article PubMed CAS Google Scholar
  5. Bagshawe, K. D. (1989) Towards generating cytotoxic agents at cancer sites. The First Bagshawe Lecture.Br. J. Cancer 60, 275–281.
    PubMed CAS Google Scholar
  6. Sharma, S. K., Bagshawe K. D., Springer, C. J., Burke, P. J., Rogers, G. T., Boden, J. A., Antoniw, P., Melton, R. G., and Sherwood, R. F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): A three-phase system.Disease Markers 9, 225–231.
    PubMed CAS Google Scholar
  7. Courtenay-Luck, N. S., Epenetos, A. A., Moore, R., Larche, M., Pectasides, D., Dhokia, B., and Ritter, M. A. (1986) Development of primary and secondary immune response to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.Cancer Res. 46, 6489–6493.
    PubMed CAS Google Scholar
  8. Schroff, R. W., Foon, K. A., Beatty, S., Oldham, R. K., and Morgan, A. C. (1985) Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.Cancer Res. 45, 879–885.
    PubMed CAS Google Scholar
  9. Shawler, D. L., Bartholomew, R. M., Smith, L. M., and Dillman, R. O. (1985) Human immune response to multiple injections of murine IgG1.J. Immunol. 135, 1530–1535.
    PubMed CAS Google Scholar
  10. LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proc. Natl. Acad. Sci. USA 86, 4220–4224.
    Article PubMed CAS Google Scholar
  11. Meredith, R. F., LoBuglio, A. F., Plott, W. E., Orr, R. A., Brezovich, I. A., Russell, C. D., Harvey, E. B., Yester, M. V., Wagner, A. J., Spencer, S. A., Wheeler, R. H., Saleh, M. N., Rogers, K. J., Polansky, A., Salter, M. M., and Khazaeli, M. B. (1991) Pharmacokinetics, immune response and biodistribution of iodine-131-labeled chimeric Mouse/human IgG1, k 17-1A monoclonal antibody.J. Nucl. Med. 32, 1162–1168.
    PubMed CAS Google Scholar
  12. Morrison, S. L. (1985) Transfectomas provide novel chimeric antibodies.Science (Washington, DC) 229, 1202–1207.
    Article CAS Google Scholar
  13. Reichman, L. C. M., Waldmann, H., and Winter, G. (1988) Reshaping human antibodies for therapy.Nature 332, 323–327.
    Article Google Scholar
  14. Haspel, M. V., McCabe, R. P., Pomato, N., Janesh, N. J., Knowlton, J. V., Peters, L. C., Hoover, H. C. Jr., and Hanna, M. G. Jr. (1985) Generation of tumour cell reactive monoclonal antibodies using peripheral blood lymphocytes from actively immunised colorectal carcinoma patients.Cancer Res. 45, 3951–3961.
    PubMed CAS Google Scholar
  15. McCabe, R. P., Peters, L. C., Haspel, M. V., Pomato, N., Carrasquillo, J. A., and Hanna, M. G. Jr. (1988) Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumours.Cancer Res. 48, 4348–4353.
    PubMed CAS Google Scholar
  16. Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H. H., Schuermann, M., and Seeman, G. (1992) Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation.Br. J. Cancer 65, 234–238.
    PubMed CAS Google Scholar
  17. Sherwood, R. F., Melton, R. G., Alwan, S. M., and Hughes, P. (1985) Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS16: use of a novel triazine dye affinity method.Eur. J. Biochem. 148, 453–477.
    Article Google Scholar
  18. Melton, R. G., Boyle, J. M. B., Rogers, G. T., Burke, P., Bagshawe, K. D., and Sherwood, R. F. (1993) Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2.J. Immunol. Meth. 158, 49–56.
    Article CAS Google Scholar
  19. Sharma, S. K., Bagshawe, K. D., Burke, P. J., Boden, R. W., and Rogers, G. T. (1990) Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.Br. J. Cancer 61, 659–662.
    PubMed CAS Google Scholar
  20. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications.J. Natl. Cancer Inst. 79, 855.
    PubMed CAS Google Scholar
  21. Springer, C. J., Bagshawe, K. D., Sharma, S. K., Searle, F., Boden, J. A., Antoniw, P., Burke, P. J., Rogers, G. T., Sherwood, R. F., and Melton, R. G. (1991) Ablation of human choriocarcinoma xenografts in nude mice by antibody directed enzyme prodrug therapy (ADEPT) with three novel compounds.Eur. J. Cancer 27, 1361–1366.
    Article PubMed CAS Google Scholar
  22. Bagshawe, K. D., Sharma, S. K., Springer, C. J. S., Antoniw, P., Boden, J. A., Roger, G. T., Burke, P. J., Melton, R. G., and Sherwood, R. F. (1991) Antibody directed enzyme prodrug therapy (ADEPT): clinical report.Disease Markers 9, 233–238.
    PubMed CAS Google Scholar
  23. Blottiere, H. M., Douillard, J. Y., Koprowski, H., and Steplewski, Z. (1990) Immunoglobulin class and immunoglobulin G subclass analysis of human antimouse antibody response during monoclonal antibody treatment of cancer patients.Cancer Res. 50(Suppl.), 1051–1054.
    Google Scholar
  24. Sharma, S. K., Bagshawe, K. D., Melton, R. G., and Sherwood, R. F. (1991) Immunogenicity of monoclonal antibody-enzyme conjugates in antibody directed enzyme prodrug therapy (ADEPT) [Abstract].Antibody, Immunoconjugates and Radiopharmaceuticals 4, 226.
    Google Scholar
  25. Ledermann, J. A., Begent, R. H. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Glaser, M. G., Green, A. J., and Dale, R. G. (1988) Repeated antitumor antibody therapy in man with suppression of the host response to Cyclosporin A.Br. J. Cancer 58, 654–657.
    PubMed CAS Google Scholar
  26. Kino, T., Hatanaka, H., and Miyata, S. (1987) FK 506, a novel immunosuppressant isolated from streptomyces. II. Immunosuppressive effect of FK506 in vivo.J. Antibiot. Tokyo 40, 1526–1565.
    Google Scholar
  27. Waldmann, H. (1989) Manipulation of T cell responses with monoclonal antibodies.Ann. Rev. Immunol. 7, 407–444.
    Article CAS Google Scholar

Download references